Blueprint Medicines Corp buy melinda
Start price
14.12.16
/
50%
€23.36
Target price
05.01.17
€27.06
Performance (%)
16.56%
End price
05.01.17
€27.23
Summary
This prediction ended on 05.01.17 with a price of €27.23. The prediction had a final performance of 16.56%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - |
| iShares Core DAX® | 3,07 % | 0,49 % | 11,39 % | 50,36 % |
| iShares Nasdaq 100 | 2,88 % | 0,08 % | 22,47 % | 81,10 % |
| iShares Nikkei 225® | 5,98 % | 3,03 % | 41,00 % | 59,47 % |
| iShares S&P 500 | 2,23 % | 0,05 % | 18,10 % | 60,47 % |
Comments by melinda for this prediction
In the thread Blueprint Medicines Corp diskutieren
folgen
a +
(Zielkurs erreicht)
Stopped prediction by melinda for Blueprint Medicines Corp
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€64.30
31.08.20
31.08.20
€66.00
04.11.21
04.11.21
55.52%
05.11.21
05.11.21
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€78.02
14.07.20
14.07.20
€100.00
31.08.20
31.08.20
-17.59%
31.08.20
31.08.20
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€76.30
26.05.19
26.05.19
€79.38
06.06.19
06.06.19
4.18%
06.06.19
06.06.19


